Mohtashmi et al., 2022)
Challenges with Access, Costs, and Supply Despite the promise of weight loss drugs, challenges remain
Przepiorka D, Giralt S, Huh YO, Andreeff M , Luna M, Reading C, Thomas M, Champlin RE
What we are not talking about enough GLP-1induced weight loss is not just fat loss Emerging concerns: Sarcopenia Up to 2540% of weight loss may be lean mass especially relevant in older adults If patients lose both fat and muscle on treatment, then stop the drug and regain mostly fat, they may not simply return to baseline
Listen to hunger cues: Stop eating as soon as you feel satisfied, even if there is food left on your plate